PharmAla Biotech Holdings, Inc.(MDXXF)
$0.10-0.01 (-6.86%)
MDXXF
PharmAla Biotech Holdings, Inc. financials statements
$0.10
At close:-0.01 (-6.86%)
PharmAla Biotech Holdings, Inc. (MDXXF) Income Statement
6 Followers
PharmAla Biotech Holdings, Inc. Income Statement
Last quarter (Q3 2026), PharmAla Biotech Holdings, Inc.'s total revenue was C$513.23K, an increase of 279.70% from the same quarter last year. In Q3, PharmAla Biotech Holdings, Inc.'s net income was C$-499.76K. See PharmAla Biotech Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Nov 25 | Nov 24 | Nov 23 | Nov 22 | Aug 21 |
|---|---|---|---|---|---|
| C$ 605.50K | C$ 1.04M | C$ 532.00K | C$ 78.07K | C$ 0.00 | |
| C$ -845.17K | C$ 887.44K | C$ 454.10K | C$ 75.78K | C$ -303.00 | |
| C$ 1.31M | C$ 1.53M | C$ 1.22M | C$ 1.06M | C$ 2.51M | |
| Depreciation and Amortization | C$ 117.05K | C$ 70.21K | C$ 52.77K | C$ 12.13K | C$ 303.00 |
| C$ -2.07M | C$ -573.36K | C$ -710.18K | C$ -973.45K | C$ -2.51M | |
| C$ -2.15M | C$ -643.57K | C$ -762.95K | C$ -985.58K | C$ -2.51M | |
| C$ -22.02K | C$ -180.03K | C$ -16.86K | C$ 0.00 | C$ 0.00 | |
| C$ -2.18M | C$ -823.60K | C$ -779.81K | C$ -985.58K | C$ -2.51M | |
| C$ -2.18M | C$ -823.60K | C$ -779.81K | C$ -985.58K | C$ -2.51M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.02 | C$ -0.01 | C$ -0.01 | C$ -0.01 | C$ -0.03 |
| Diluted EPS | C$ -0.02 | C$ -0.01 | C$ -0.01 | C$ -0.01 | C$ -0.03 |
| Weighted Average Shares Outstanding | 99.58M | 88.57M | 84.53M | 83.00M | 83.00M |
| Weighted Average Shares Outstanding (Diluted) | 99.58M | 88.57M | 84.53M | 83.00M | 83.00M |
Currency in CAD

